Lv21
104 积分 2025-06-30 加入
Structure-Guided Discovery of Novel Dual-Site FEM1B Ligands and Assessment of Their Use in Targeted Protein Degradation
1天前
已完结
Structure-Guided Discovery of Novel Dual-Site FEM1B Ligands and Assessment of Their Use in Targeted Protein Degradation
2天前
已完结
Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation Simulations
3天前
已完结
Polypharmacological Targeting of G2019S Mutant LRRK2 and JNK3 for the Discovery of a Lead Compound against Parkinson’s Disease
4天前
已完结
Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment
9天前
已完结
Cancer Research Communications
9天前
已关闭
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
13天前
已完结
Design, simulate, refine: simulation-guided clinical trials for accelerated drug development
15天前
已完结
Antibody Affinity Maturation by Computational Design
17天前
已关闭
Antibody Design and Humanization via In Silico Modeling
17天前
已完结
皖公网安备34019202002308
